© 1999 American Heart Association, Inc.
Original Contributions |
Oxidized LDL Can Induce Macrophage Survival, DNA Synthesis, and Enhanced Proliferative Response to CSF-1 and GM-CSF
From the Inflammation Research Centre, University of Melbourne, The Royal Melbourne Hospital, Parkville (J.A.H., D.M., F.C., R.B., G.W., S.M.), and the Heart Research Institute, Camperdown (W.J.), Australia.
Correspondence to Professor John Hamilton, Inflammation Research Centre, University of Melbourne, Department of Medicine, The Royal Melbourne Hospital, Clinical Sciences Building, Royal Parade, Parkville 3050, Australia. E-mail j.hamilton{at}medicine.unimelb.edu.au
Abstract—Modification of low density lipoprotein (LDL), eg, by oxidation, has been proposed as being important for the formation of foam cells and therefore for the development of atherosclerotic plaques. There are a number of reports showing that macrophage-derived foam cells can proliferate in both human and animal lesions, particularly in the early phase of the disease and possibly involving macrophage-colony stimulating factor (M-CSF, or CSF-1). We studied the in vitro effects of oxidized LDL (ox-LDL) on murine bone marrow–derived macrophages (BMMs), a cell population with a high proliferative capacity in vitro in response to CSF-1 and a dependence for survival on the presence of this growth factor. We report here that treatment of BMMs with low doses of ox-LDL, but not with native LDL, led to cell survival, DNA synthesis, and an enhanced response to the proliferative actions of CSF-1 and granulocyte macrophage-CSF (GM-CSF); the effects were dependent on the degree of LDL oxidation. For CSF-1, a synergistic effect was noticeable at suboptimal doses. The effect of ox-LDL occurred even in the absence of endogenous CSF-1 or GM-CSF. Our findings suggest that ox-LDL, and possibly other modified forms of LDL, could maintain macrophage (and foam cell) survival and therefore lengthen their tenure in a plaque; the modified LDL could also cause local macrophage proliferation or "prime" them so that they could proliferate better in response to CSF-1 (and GM-CSF) concentrations that may be present in the atheroma.
Key Words: oxidized LDL • macrophages • proliferation • colony stimulating factor-1 • granulocyte macrophage-colony stimulating factor
This article has been cited by other articles:
 |
|
 |
|
  C. L. Elsegood, M. Chang, W. Jessup, G. M. Scholz, and J. A. Hamilton Glucose Metabolism Is Required for Oxidized LDL-Induced Macrophage Survival: Role of PI3K and Bcl-2 Family Proteins Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1283 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Schaeffer, M. Riazy, K. S. Parhar, J. H. Chen, V. Duronio, T. Sawamura, and U. P. Steinbrecher LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma J. Lipid Res., August 1, 2009; 50(8): 1676 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Chen, M. Riazy, E. M. Smith, C. G. Proud, U. P. Steinbrecher, and V. Duronio Oxidized LDL-Mediated Macrophage Survival Involves Elongation Factor-2 Kinase Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tian, S. E. Kelemen, and M. V. Autieri Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1083 - C1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Conway and M. Kinter Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL Mol. Cell. Proteomics, October 1, 2005; 4(10): 1522 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Senokuchi, T. Matsumura, M. Sakai, M. Yano, T. Taguchi, T. Matsuo, K. Sonoda, D. Kukidome, K. Imoto, T. Nishikawa, et al. Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK Pathway J. Biol. Chem., February 25, 2005; 280(8): 6627 - 6633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lamharzi, C. B. Renard, F. Kramer, S. Pennathur, J. W. Heinecke, A. Chait, and K. E. Bornfeldt Hyperlipidemia in Concert With Hyperglycemia Stimulates the Proliferation of Macrophages in Atherosclerotic Lesions: Potential Role of Glucose-Oxidized LDL Diabetes, December 1, 2004; 53(12): 3217 - 3225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cuaz-Perolin, C. Furman, G. Larigauderie, L. Legedz, C. Lasselin, C. Copin, M. Jaye, G. Searfoss, K.T. Yu, N. Duverger, et al. REDD2 Gene Is Upregulated by Modified LDL or Hypoxia and Mediates Human Macrophage Cell Death Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1830 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gomez-Munoz, J. Y. Kong, B. Salh, and U. P. Steinbrecher Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages J. Lipid Res., January 1, 2004; 45(1): 99 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Hundal, A. Gomez-Munoz, J. Y. Kong, B. S. Salh, A. Marotta, V. Duronio, and U. P. Steinbrecher Oxidized Low Density Lipoprotein Inhibits Macrophage Apoptosis by Blocking Ceramide Generation, Thereby Maintaining Protein Kinase B Activation and Bcl-XL Levels J. Biol. Chem., June 27, 2003; 278(27): 24399 - 24408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hamilton Nondisposable materials, chronic inflammation, and adjuvant action J. Leukoc. Biol., June 1, 2003; 73(6): 702 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce OxLDL stimulates cell proliferation through a general induction of cell cycle proteins Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H644 - H653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Salh, K. Assi, S. Huang, L. O'Brien, U. Steinbrecher, and A. Gomez-Munoz Dissociated ROS production and ceramide generation in sulfasalazine-induced cell death in Raw 264.7 cells J. Leukoc. Biol., October 1, 2002; 72(4): 790 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tan, A. Mui, and S. Dedhar Integrin-linked Kinase Regulates Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Expression in an NF-kappa B-dependent Manner J. Biol. Chem., January 25, 2002; 277(5): 3109 - 3116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hayden, L. Brachova, K. Higgins, L. Obermiller, A. Sevanian, S. Khandrika, and P. D. Reaven Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol J. Lipid Res., January 1, 2002; 43(1): 26 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Hundal, B. S. Salh, J. W. Schrader, A. Gomez-Munoz, V. Duronio, and U. P. Steinbrecher Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway J. Lipid Res., September 1, 2001; 42(9): 1483 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aikawa and P. Libby Vascular inflammation and activation: new targets for lipid lowering Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B3 - B11. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Aikawa, E. Rabkin, S. Sugiyama, S. J. Voglic, Y. Fukumoto, Y. Furukawa, M. Shiomi, F. J. Schoen, and P. Libby An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro Circulation, January 16, 2001; 103(2): 276 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. HEINLOTH, K. HEERMEIER, U. RAFF, C. WANNER, and J. GALLE Stimulation of NADPH Oxidase by Oxidized Low-Density Lipoprotein Induces Proliferation of Human Vascular Endothelial Cells J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1819 - 1825. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Hamilton, G. Whitty, and W. Jessup Oxidized LDL Can Promote Human Monocyte Survival Arterioscler Thromb Vasc Biol, October 1, 2000; 20 (10): 2329 - 2331. [Full Text] [PDF]
|
|
|
|
|
|
T. Biwa, M. Sakai, T. Matsumura, S. Kobori, K. Kaneko, A. Miyazaki, H. Hakamata, S. Horiuchi, and M. Shichiri Sites of Action of Protein Kinase C and Phosphatidylinositol 3-Kinase Are Distinct in Oxidized Low Density Lipoprotein-induced Macrophage Proliferation J. Biol. Chem., February 25, 2000; 275(8): 5810 - 5816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Matsumura, M. Sakai, K. Matsuda, N. Furukawa, K. Kaneko, and M. Shichiri Cis-acting DNA Elements of Mouse Granulocyte/Macrophage Colony-stimulating Factor Gene Responsive to Oxidized Low Density Lipoprotein J. Biol. Chem., December 31, 1999; 274(53): 37665 - 37672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C. Gelissen, K.-A. Rye, A. J. Brown, R. T. Dean, and W. Jessup Oxysterol efflux from macrophage foam cells: the essential role of acceptor phospholipid J. Lipid Res., September 1, 1999; 40(9): 1636 - 1646. [Abstract] [Full Text]
|
|